TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32208168

Group type: EXPERIMENTAL
Intervention: INO-5150 (2 mg)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: INO-5150 (8.5 mg)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: INO-5150 (2 mg) + INO-9012 (1 mg)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: INO-5150 (8.5 mg) + INO-9012 (1 mg)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: CD38 and perforin co-positive CD8 T cells
Number of subjects: 62
Study: 35253707

Group type: EXPERIMENTAL
Intervention: Kinesiotape (KT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: False kinesiotape (FKT)
Number of subjects: 28
Study: 32447474

Group type: EXPERIMENTAL
Intervention: Anlotinib with HFS at any time
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Anlotinib with HFS in the first 2 cycles
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Anlotinib with varying severity of HFS
Number of subjects: 294
Study: 32947608

Group type: EXPERIMENTAL
Intervention: Microbial and clinical features
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Microbial features only
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Microbial and bio-clinical features including fasting glycaemic measures
Number of subjects: 106
Study: 36329519

Group type: EXPERIMENTAL
Intervention: WHO6S
Number of subjects: 427

Group type: COMPARATOR
Intervention: A6Sw/oI
Number of subjects: 427
Study: 32105341

Group type: EXPERIMENTAL
Intervention: NaOCl + PDT
Number of subjects: 120

Group type: COMPARATOR
Intervention: NaOCl
Number of subjects: 120

Group type: COMPARATOR
Intervention: NaOCl + EDTA
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: NaOCl + EDTA + PDT
Number of subjects: 120
Study: 36349571

Group type: EXPERIMENTAL
Intervention: PEEP titration to the lowest driving pressure
Number of subjects: 207

Group type: COMPARATOR
Intervention: Conventional low level of PEEP (4 cm H2O)
Number of subjects: 207
Study: 36346936

Group type: EXPERIMENTAL
Intervention: Telehealth lifestyle-coaching program (Liva)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 340
Study: 32591439

Group type: EXPERIMENTAL
Intervention: Intensive hypertension treatment (targeting systolic BP <120 mm Hg)
Number of subjects: 9361

Group type: COMPARATOR
Intervention: Standard hypertension treatment (targeting systolic BP <140 mm Hg)
Number of subjects: 9361

Group type: EXPERIMENTAL
Intervention: Declining kidney function measured by eGFR
Number of subjects: 9361

Group type: EXPERIMENTAL
Intervention: Incident eGFR <60 ml/min per 1.73 m2
Number of subjects: 9361

Group type: EXPERIMENTAL
Intervention: Baseline and incident urinary ACR ≥30 mg/g
Number of subjects: 9361
Study: 34657407

Group type: EXPERIMENTAL
Intervention: Routine monitoring of cardiac troponin (cTn) levels during the first 48 hours post-operation in high-risk patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of cardiovascular drugs (aspirin, antihypertensives, statins)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Direct oral anticoagulants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Myocardial injury detected before noncardiac surgery
Number of subjects: 0
Study: 33722218

Group type: EXPERIMENTAL
Intervention: Family dinner ≥4 times/week
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Each additional meal category eaten with family ≥4 times/week
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: Family meals
Number of subjects: 408
Study: 32203675

Group type: EXPERIMENTAL
Intervention: Accelerated rehabilitation (graduated weightbearing at 2 weeks)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Traditional rehabilitation (weightbearing at 6 weeks)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Accelerated rehabilitation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Traditional rehabilitation
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 18
Study: 33994954

Group type: EXPERIMENTAL
Intervention: iTBS plus MT
Number of subjects: 18

Group type: COMPARATOR
Intervention: sham iTBS plus MT
Number of subjects: 18

Group type: COMPARATOR
Intervention: real MT
Number of subjects: 18
Study: 32448722

Group type: EXPERIMENTAL
Intervention: Resistant starch supplementation (35 g/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35921606

Group type: EXPERIMENTAL
Intervention: New cancer drugs
Number of subjects: 331

Group type: COMPARATOR
Intervention: Initial indications
Number of subjects: 331
Study: 34393120

Group type: EXPERIMENTAL
Intervention: 2.5% lidocaine/2.5% prilocaine topical anesthetic
Number of subjects: 0

Group type: COMPARATOR
Intervention: Injection anesthetic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: L/P topical anesthetic
Number of subjects: 0
Study: 35466800

Group type: EXPERIMENTAL
Intervention: Counselling program based on cognitive behavioural therapy (16 sessions)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no counselling program)
Number of subjects: 22
Study: 32213303

Group type: EXPERIMENTAL
Intervention: Plasma suPAR level above 3.70 ng mL-1
Number of subjects: 1190
Study: 34643947

Group type: EXPERIMENTAL
Intervention: Neoadjuvant anthracycline plus ifosfamide (AI)
Number of subjects: 1001

Group type: EXPERIMENTAL
Intervention: Histology-tailored (HT) chemotherapy
Number of subjects: 1001
Study: 36192605

Group type: EXPERIMENTAL
Intervention: HIIT bike
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: HIIT short-treadmill
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: HIIT long-treadmill
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study: 32114806

Group type: EXPERIMENTAL
Intervention: Patellofemoral arthroplasty (PFA)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Total knee arthroplasty (TKA)
Number of subjects: 64
Study: 34954837

Group type: EXPERIMENTAL
Intervention: Alcohol-based hand sanitizers (ABHS)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Disinfectant wipes
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Water and soap
Number of subjects: 62
Study: 33595901

Group type: EXPERIMENTAL
Intervention: Insulin degludec/liraglutide (IDegLira)
Number of subjects: 1029

Group type: COMPARATOR
Intervention: Insulin degludec
Number of subjects: 1029
Study: 33094898

Group type: EXPERIMENTAL
Intervention: Manual therapy and passive muscle stretching exercises
Number of subjects: 28
Study: 33017854

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 433

Group type: COMPARATOR
Intervention: Placebo (PLAC)
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (GPT)
Number of subjects: 433

Group type: COMPARATOR
Intervention: Clinical Management (CM)
Number of subjects: 433
Study: 33170356

Group type: EXPERIMENTAL
Intervention: Creative advertisements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Insight experience
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard advertisements
Number of subjects: 0
Study: 36482693

Group type: EXPERIMENTAL
Intervention: Caregiver-only educational intervention with telephone follow-up
Number of subjects: 37
Study: 32219638

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 49
Study: 33846088

Group type: EXPERIMENTAL
Intervention: Heat acclimation (HOT) - 40 °C, 40% relative humidity, n = 16, 5 days of acclimation with exercise sessions
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (CON) - 23 °C, 25% relative humidity, n = 8
Number of subjects: 24
Study: 36413049

Group type: EXPERIMENTAL
Intervention: 2gether intervention
Number of subjects: 685

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 685
Study: 34437784

Group type: EXPERIMENTAL
Intervention: elexacaftor-tezacaftor-ivacaftor
Number of subjects: 258

Group type: COMPARATOR
Intervention: active control
Number of subjects: 258
Study: 33264200

Group type: EXPERIMENTAL
Intervention: BMS intervention (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU) group (n = 30)
Number of subjects: 60
Study: 35793883

Group type: EXPERIMENTAL
Intervention: Medical rehabilitation plus flexibility training
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Flexibility training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 33823924

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB) with 0.375% ropivacaine 0.4 ml/kg
Number of subjects: 166

Group type: COMPARATOR
Intervention: Thoracic paravertebral block (TPVB) with 0.375% ropivacaine 0.4 ml/kg
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Thoracic paravertebral block (TPVB)
Number of subjects: 166
Study: 35817286

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg/day)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Methylprednisolone (60 mg/day in two divided doses)
Number of subjects: 143
Study: 33401397

Group type: EXPERIMENTAL
Intervention: Continuous cycling ergometer (55% VO2max)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Physical activity strength program
Number of subjects: 60

Group type: COMPARATOR
Intervention: Moderate-intensity physical activity program
Number of subjects: 60
Study: 32272777

Group type: EXPERIMENTAL
Intervention: LF-containing yogurt (100 mg/day)
Number of subjects: 1296

Group type: COMPARATOR
Intervention: Control group (fruit jelly)
Number of subjects: 1296
Study: 33243964

Group type: EXPERIMENTAL
Intervention: Red noise
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Pink noise
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: White noise
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Red and pink noise
Number of subjects: 22
Study: 36316797

Group type: EXPERIMENTAL
Intervention: Descemet Membrane Endothelial Keratoplasty (DMEK)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Ultrathin Descemet Stripping Automated Endothelial Keratoplasty (UT-DSAEK)
Number of subjects: 53
Study: 33876660

Group type: EXPERIMENTAL
Intervention: Song of Life music therapy intervention
Number of subjects: 104

Group type: COMPARATOR
Intervention: Relaxation intervention (control group)
Number of subjects: 104
Study: 36494503

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 60

Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 60
Study: 34225757

Group type: EXPERIMENTAL
Intervention: 1 or 2 HEPA filter air cleaners
Number of subjects: 478

Group type: COMPARATOR
Intervention: No air cleaners (Control)
Number of subjects: 478

Group type: EXPERIMENTAL
Intervention: First trimester PM2.5 concentration increase (20.1 µg/m3)
Number of subjects: 478

Group type: EXPERIMENTAL
Intervention: Third trimester PM2.5 concentrations
Number of subjects: 478

Group type: EXPERIMENTAL
Intervention: Second trimester PM2.5 concentrations
Number of subjects: 478
Study: 33120779

Group type: EXPERIMENTAL
Intervention: Phone assistance nursing program (extra coaching sessions on self-care, exercise guidance)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard management (control group, exercises at home not monitored)
Number of subjects: 90
Study: 35622060

Group type: EXPERIMENTAL
Intervention: PR/RP+SIM/methylcellulose (MCL); n = 27
Number of subjects: 50

Group type: COMPARATOR
Intervention: PR/RP+methylcellulose (MCL); n = 23
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: PR/RP+SIM/methylcellulose (MCL)
Number of subjects: 50

Group type: COMPARATOR
Intervention: PR/RP+methylcellulose (MCL)
Number of subjects: 50
Study: 33136069

Group type: EXPERIMENTAL
Intervention: Continuous heart rate characteristics (HRC) monitoring
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: Prophylactic antibiotics after UTI
Number of subjects: 823

Group type: COMPARATOR
Intervention: No uroprophylaxis after first UTI
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: Renal ultrasounds (RUS) after UTI
Number of subjects: 823

Group type: EXPERIMENTAL
Intervention: Voiding cystourethrograms (VCUG)
Number of subjects: 823
Study: 32897665

Group type: EXPERIMENTAL
Intervention: Electrical muscle stimulation
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control
Number of subjects: 42
Study: 36266337

Group type: EXPERIMENTAL
Intervention: Integrated host-microbe plasma metagenomics
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Plasma RNA transcriptional signature
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Secondary transcriptomic classifier for virus detection
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Integrated sepsis diagnostic model
Number of subjects: 221
Study: 34491026

Group type: EXPERIMENTAL
Intervention: HARC
Number of subjects: 210

Group type: COMPARATOR
Intervention: Control
Number of subjects: 210
Study: 36250415

Group type: EXPERIMENTAL
Intervention: Laparoscopic Sleeve Gastrectomy (LSG)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Roux‐En‐Y Gastric Bypass (RYGB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate TKR
Number of subjects: 0

Group type: COMPARATOR
Intervention: No weight loss/no TKR
Number of subjects: 0
Study: 35924869

Group type: EXPERIMENTAL
Intervention: STRIDE (telehealth intervention)
Number of subjects: 100

Group type: COMPARATOR
Intervention: MedMon (medication monitoring control)
Number of subjects: 100
Study: 32725244

Group type: EXPERIMENTAL
Intervention: Stepwise approach including 6-month lifestyle modification curriculum plus metformin
Number of subjects: 578

Group type: COMPARATOR
Intervention: Standard lifestyle advice
Number of subjects: 578
Study: 33180913

Group type: EXPERIMENTAL
Intervention: Sleep Coach Jr. intervention (educational materials and three individual phone calls); N = 20
Number of subjects: 39

Group type: COMPARATOR
Intervention: Standard Care condition; N = 19
Number of subjects: 39
Study: 36501086

Group type: EXPERIMENTAL
Intervention: Ferric Carboxymaltose (FCM) 500 mg IV infusion, given at time 0 and repeated after 4 weeks
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo (100 mL of saline given i.v. in 10 min), n = 32
Number of subjects: 64
Study: 32232540

Group type: EXPERIMENTAL
Intervention: Unilateral cerebellar rTMS (10 Hz)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Bilateral cerebellar rTMS (10 Hz)
Number of subjects: 13
Study: 35850873

Group type: EXPERIMENTAL
Intervention: Airborne-particle abrasion (APA)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Tribochemical silica airborne-particle abrasion (TS)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Nonthermal oxygen plasma (NTP)
Number of subjects: 169

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 169
Study: 34836336

Group type: EXPERIMENTAL
Intervention: Cooked coix seed (160 g per day) for 7 days
Number of subjects: 19
Study: 33966521

Group type: EXPERIMENTAL
Intervention: Diuretic adjustment algorithm (DAA) with telephone follow-ups for 30 days
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Diuretic adjustment algorithm (DAA)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Control group (CG) - diuretic dose adjusted by physician at baseline only
Number of subjects: 206
Study: 33051975

Group type: EXPERIMENTAL
Intervention: Tripeptide/hexapeptide serum
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bland moisturizer
Number of subjects: 20
Study: 36268587

Group type: EXPERIMENTAL
Intervention: Sacral massage
Number of subjects: 220
Study: 34287817

Group type: EXPERIMENTAL
Intervention: rTPJ anodal high-definition transcranial direct current stimulation
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: dmPFC anodal high-definition transcranial direct current stimulation
Number of subjects: 52

Group type: COMPARATOR
Intervention: Sham stimulation (control)
Number of subjects: 52
Study: 32846573

Group type: EXPERIMENTAL
Intervention: Mango juice by-product (JBP) beverage (0.04 g·ml-1)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Flavored water (control group)
Number of subjects: 100
Study: 36501091

Group type: EXPERIMENTAL
Intervention: High-nutrient-quality diet
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Low-nutrient-quality diet
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Baseline postprandial FGF21 response
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Higher habitual polysaccharide intake
Number of subjects: 110
Study: 34674670

Group type: EXPERIMENTAL
Intervention: Intravenous ibuprofen 10 mg/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 40
Study: 32353739

Group type: EXPERIMENTAL
Intervention: Randomized SVD (rSVD) clutter filtering with a downsampling factor of 12 and 12 threads on a 12-core CPU.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized SVD (rSVD) clutter filtering with a block size of 20x20 pixels, ensemble size 45, and rank of tissue clutter subspace 26.
Number of subjects: 0
Study: 34881942

Group type: EXPERIMENTAL
Intervention: Jungian psychotherapy (JP) with a focus on spirituality and synchronicity
Number of subjects: 0
Study: 32173020

Group type: EXPERIMENTAL
Intervention: Canal preparation using Protaper Next files until size X3
Number of subjects: 18

Group type: COMPARATOR
Intervention: Canal preparation using Protaper Next files until size X5
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both groups (X3 and X5)
Number of subjects: 18
Study: 33706602

Group type: EXPERIMENTAL
Intervention: Clinically indicated replacement
Number of subjects: 600

Group type: COMPARATOR
Intervention: Routine replacement
Number of subjects: 600
Study: 34073610

Group type: EXPERIMENTAL
Intervention: 500 g daily of bitter and strong-tasting (BST) vegetables
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 500 g daily of mild and sweet-tasting (MST) vegetables
Number of subjects: 92

Group type: COMPARATOR
Intervention: 120 g daily MST normal diet (control)
Number of subjects: 92
Study: 36113110

Group type: EXPERIMENTAL
Intervention: Nonsupervised physical activity (30 min of self-administered physical aerobic activity daily for 2 weeks before and 4 weeks after surgery)
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Nonsupervised physical activity
Number of subjects: 354

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy subgroup
Number of subjects: 354
Study: 33963058

Group type: EXPERIMENTAL
Intervention: Whole blood donation every 12 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Plasma donation every 6 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 32314505

Group type: EXPERIMENTAL
Intervention: 2.4 mg/kg GLP-1-gFc
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.6 mg/kg dulaglutide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.28 mg/kg GLP-1-gFc
Number of subjects: 0

Group type: COMPARATOR
Intervention: 0.07 mg/kg dulaglutide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GLP-1-gFc
Number of subjects: 0

Group type: COMPARATOR
Intervention: dulaglutide
Number of subjects: 0
Study: 35449803

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training rehabilitation for 26 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no aerobic exercise training)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training rehabilitation
Number of subjects: 0
Study: 33148771

Group type: EXPERIMENTAL
Intervention: Home visiting
Number of subjects: 1449

Group type: EXPERIMENTAL
Intervention: Group sessions
Number of subjects: 1449

Group type: COMPARATOR
Intervention: Nutritional education
Number of subjects: 1449
Study: 34303223

Group type: EXPERIMENTAL
Intervention: High-closeness discussion
Number of subjects: 105

Group type: COMPARATOR
Intervention: Low-closeness discussion
Number of subjects: 105
Study: 32584613

Group type: EXPERIMENTAL
Intervention: Young patient cohort (aged 18 to 40)
Number of subjects: 59
Study: 35039192

Group type: EXPERIMENTAL
Intervention: High-Intensity Focused Ultrasound Ablation (HIFUA)
Number of subjects: 42
Study: 32648641

Group type: EXPERIMENTAL
Intervention: Peanut protein ingestion (300-1000 mg)
Number of subjects: 20
Study: 32404169

Group type: EXPERIMENTAL
Intervention: Aloe vera 3% topical ointment
Number of subjects: 42
Study: 36305561

Group type: EXPERIMENTAL
Intervention: Higher power short duration (HPSD) ablation at 40 W
Number of subjects: 88

Group type: COMPARATOR
Intervention: Lower power longer duration (LPLD) ablation at 25 W
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Higher power short duration (HPSD) ablation
Number of subjects: 88

Group type: COMPARATOR
Intervention: Lower power longer duration (LPLD) ablation
Number of subjects: 88
Study: 34348775

Group type: EXPERIMENTAL
Intervention: 38% Silver Diamine Fluoride (SDF)
Number of subjects: 688

Group type: COMPARATOR
Intervention: 5% Sodium Fluoride (NaF) varnish
Number of subjects: 688
Study: 34392814

Group type: EXPERIMENTAL
Intervention: Avoiding screen use in bed
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Avoiding caffeine, alcohol and cigarettes before bedtime
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Having a regular bedtime and wake up time even on weekends
Number of subjects: 30
Study: 32512259

Group type: EXPERIMENTAL
Intervention: Ancient samples (C-shaped root canals)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (modern samples)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Ancient samples (C-shaped canals classification)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Ancient samples (fused root and groove types)
Number of subjects: 38
Study: 35569763

Group type: EXPERIMENTAL
Intervention: 1-mg intravitreal risuteganib injection
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 39
Study: 32973056

Group type: EXPERIMENTAL
Intervention: 3D printed models (3DP)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Virtual reality models (VR)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Normal physical models (NP)
Number of subjects: 153
Study: 34419209

Group type: EXPERIMENTAL
Intervention: L3-700 (50 L3 larvae, UVC-attenuated)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo (Tabasco sauce)
Number of subjects: 22
Study: 32819441

Group type: EXPERIMENTAL
Intervention: Ear acupressure (Vaccaria seed)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Sham control (non-latex-based adhesives with no Vaccaria seeds)
Number of subjects: 76
Study: 35387826

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 0
Study: 34202762

Group type: EXPERIMENTAL
Intervention: High cognitive exertion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Low cognitive exertion
Number of subjects: 10